Back to Type 2 Diabetes
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00613782

NCT00613782
Completed Phase 3 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Type 2 diabetes
  • Your testosterone level is below a certain low level (less than 10 nmol/L — confirm with trial site for what this means for you)

Who may not be able to join:

  • You have a medical reason why you cannot take testosterone (confirm with trial site)
  • You have a medical reason why you cannot receive injections into the muscle (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 3
Sponsor
Austin Health
Registry
clinicaltrials_gov
Start date
1 January 2009
Est. completion
1 January 2014

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Insulin Resistance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov